Source: Anais. Conference titles: Pancreatic Cancer2004: advances and challenges. Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS (QUIMIOTERAPIA), METÁSTASE NEOPLÁSICA, MUTAÇÃO GENÉTICA, METÁSTASE LINFÁTICA, RESUMOS (EVENTOS)
ABNT
MORIOKA, Cintia A et al. Antisense oligonucleotides targeted K-ras oncogene: is it a good challenge in the treatment in hamster experimental pancreatic cancer model in vitro and in vivo? 2004, Anais.. San Francisco: Faculdade de Medicina, Universidade de São Paulo, 2004. . Acesso em: 14 out. 2024.APA
Morioka, C. A., Machado, M. C. C., Saito, S., Matheus, A. S., Jukemura, J., Bacchella, T., & Watanabe, A. (2004). Antisense oligonucleotides targeted K-ras oncogene: is it a good challenge in the treatment in hamster experimental pancreatic cancer model in vitro and in vivo? In Anais. San Francisco: Faculdade de Medicina, Universidade de São Paulo.NLM
Morioka CA, Machado MCC, Saito S, Matheus AS, Jukemura J, Bacchella T, Watanabe A. Antisense oligonucleotides targeted K-ras oncogene: is it a good challenge in the treatment in hamster experimental pancreatic cancer model in vitro and in vivo? Anais. 2004 ;[citado 2024 out. 14 ]Vancouver
Morioka CA, Machado MCC, Saito S, Matheus AS, Jukemura J, Bacchella T, Watanabe A. Antisense oligonucleotides targeted K-ras oncogene: is it a good challenge in the treatment in hamster experimental pancreatic cancer model in vitro and in vivo? Anais. 2004 ;[citado 2024 out. 14 ]